|
|||||
|
|

Wireless chipmaker Qualcomm (NASDAQ:QCOM) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $12.25 billion. On the other hand, next quarter’s revenue guidance of $10.6 billion was less impressive, coming in 4.9% below analysts’ estimates. Its non-GAAP profit of $3.50 per share was 2.9% above analysts’ consensus estimates.
Is now the time to buy QCOM? Find out in our full research report (it’s free for active Edge members).
Qualcomm’s fourth quarter results were met with a negative market reaction, despite the company meeting Wall Street’s revenue expectations and exceeding consensus for non-GAAP profit. Management attributed the quarter’s performance to robust demand in premium handsets, continued expansion in automotive and industrial IoT, and strong adoption of Snapdragon platforms across devices. CEO Cristiano Amon explained that flagship smartphone launches and broadening market traction for Snapdragon, particularly in automotive and PC segments, were central to the quarter’s revenue growth. However, management also acknowledged that industry-wide memory shortages, especially for DRAM, began impacting customer inventory decisions late in the quarter.
Looking forward, Qualcomm’s guidance reflects caution, as management expects ongoing constraints in memory availability to limit handset production and impact near-term results. Amon noted that several major OEMs, especially in China, are reducing chipset inventory due to memory supply uncertainty. While management remains optimistic about strong consumer demand for premium smartphones and continued growth in automotive and IoT, CFO Akash Palkhiwala cautioned that industry dynamics around memory supply and pricing will define the company’s performance, stating that "the size of the handset market...is going to be defined by the availability of DRAM."
Management emphasized that Q4 growth was driven by strength in premium smartphones, automotive design wins, and momentum in industrial IoT, while memory supply constraints are now shaping near-term expectations.
Qualcomm’s outlook is shaped by ongoing memory supply constraints, continued diversification into automotive and industrial markets, and strategic investments in AI and edge computing.
In the coming quarters, our analysts will watch (1) signs of normalization in DRAM supply and its impact on handset production, (2) the pace of revenue growth and design wins in automotive and industrial IoT, and (3) the commercial adoption of Snapdragon-powered PCs and AI-focused devices. Execution in new markets such as robotics and updates on data center product roadmaps will also be important indicators for Qualcomm’s broader diversification strategy.
Qualcomm currently trades at $134.48, down from $145.37 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-05 | |
| Mar-05 | |
| Mar-05 | |
| Mar-05 | |
| Mar-04 | |
| Mar-04 | |
| Mar-04 | |
| Mar-04 | |
| Mar-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite